DAPA VILDA 50/5

Description

DAPA VILDA 50/5 Dapagliflozin (5mg), Vildagliptin SR (50mg) Dapagliflozin+Vildagliptin is used in the treatment of type 2 diabetes mellitus. Introduction DAPA VILDA 50/5 is a combination medication that includes Dapagliflozin (5mg) and Vildagliptin SR (50mg). This medication is used to manage type 2 diabetes mellitus by helping control blood glucose levels. By combining an SGLT2 inhibitor and a DPP-4 inhibitor, DAPA VILDA 50/5 offers a comprehensive approach to diabetes management. Active Ingredients Dapagliflozin (5mg) Dapagliflozin is an SGLT2 (sodium-glucose co-transporter 2) inhibitor that works by preventing the reabsorption of glucose in the kidneys, leading to the excretion of glucose through the urine. This helps lower blood glucose levels and can also aid in weight loss and reduce blood pressure. Vildagliptin SR (50mg) Vildagliptin is a DPP-4 (dipeptidyl peptidase-4) inhibitor that increases the levels of incretin hormones, which help to regulate glucose metabolism by enhancing the secretion of insulin and suppressing the release of glucagon. This helps to maintain blood glucose levels within the normal range, especially after meals. Uses DAPA VILDA 50/5 is used for: Type 2 Diabetes Management: Helps control blood sugar levels in patients with type 2 diabetes. Complementary Therapy: Can be used alongside diet and exercise to improve glycemic control. Reduction of Cardiovascular Risk: May help in reducing the risk of cardiovascular events in diabetic patients. Dosage The typical dosage of DAPA VILDA 50/5 is one tablet daily, taken orally. It is essential to follow the prescribing doctor's instructions and not to alter the dosage without consulting a healthcare provider. This medication can be taken with or without food. Side Effects Common side effects of DAPA VILDA 50/5 may include: Urinary Tract Infections (UTIs): Due to increased glucose in the urine. Genital Infections: Such as yeast infections. Hypoglycemia: Especially when used with other antidiabetic medications. Nausea: Mild gastrointestinal disturbances. Headache: Typically mild and transient. Serious side effects are rare but may include: Dehydration: Due to increased urination. Ketoacidosis: A rare but serious condition that requires immediate medical attention. Allergic Reactions: Such as rash, itching, or swelling, especially of the face, tongue, or throat. Precautions Before starting DAPA VILDA 50/5, inform your doctor if you have: Kidney Problems: As Dapagliflozin may not be suitable for those with severe kidney disease. Liver Problems: Dosage adjustments may be necessary. Allergies: To Dapagliflozin, Vildagliptin, or any other medications. Pregnancy or Breastfeeding: This medication should be avoided unless deemed necessary by a healthcare provider. Drug Interactions DAPA VILDA 50/5 can interact with other medications. Inform your doctor about all the medications you are taking, including: Insulin or Insulin Secretagogues: May increase the risk of hypoglycemia. Diuretics: May enhance the risk of dehydration. ACE Inhibitors: May alter blood glucose levels. Conclusion DAPA VILDA 50/5, combining Dapagliflozin and Vildagliptin, is an effective therapy for managing type 2 diabetes mellitus. By addressing blood glucose levels through different mechanisms, this combination provides a comprehensive approach to diabetes care. Always consult with your healthcare provider to ensure DAPA VILDA 50/5 is the right medication for your condition and to understand the potential risks and benefits associated with its use. Proper management of diabetes with DAPA VILDA 50/5 can lead to improved glycemic control and overall health. For further information: EMAIL: info@sterispharma.com / contact@sterispharma.com CALL/WHATSAPP: 7877551268, 7849827488 Order NOW https://www.sterisonline.com/product/dapa-vilda-50-5-134374